Protocol Ledger

NCT06008795 · Phase II · RECRUITING

BLOCK-SAH - PPF-Block for Post-SAH Headache

Interventional Phase II clinical trial protocol NCT06008795 sponsored by University of Florida in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-12-17 Enrollment: 195 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06008795
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)195 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06008795
Protocol FieldVerified Registry Value
NCT IdentifierNCT06008795
Consolidated Lead SponsorUniversity of Florida
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment195 participants (ESTIMATED)
Registered Start Date2023-12-17
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06008795
Hospital Research SiteLocationSite Profile
University of FloridaGainesville, FLOpen Hospital Dossier ->
University of MiamiMiami, FLOpen Hospital Dossier ->
Emory Winship Cancer InstituteAtlanta, GAOpen Hospital Dossier ->
University of North CarolinaChapel Hill, NCOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI